Clinical Trial Update: Mitralign Percutaneous Annuloplasty First in Man Study [NA]

View source ↗

Summary

This update reports the completion of the first-in-man study of the Mitralign Percutaneous Annuloplasty device for functional mitral regurgitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Mitral Regurgitation

Drugs mentioned

• Mitralign Percutaneous Annuloplasty

Snippet

Sponsor: Mitralign, Inc. | Conditions: Functional Mitral Regurgitation | NA | Status: COMPLETED